1. Home
  2. CIG vs BLCO Comparison

CIG vs BLCO Comparison

Compare CIG & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comp En De Mn Cemig ADS

CIG

Comp En De Mn Cemig ADS

HOLD

Current Price

$2.00

Market Cap

5.8B

Sector

Utilities

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.44

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIG
BLCO
Founded
1952
1853
Country
Brazil
Canada
Employees
N/A
N/A
Industry
Electric Utilities: Central
Ophthalmic Goods
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CIG
BLCO
Price
$2.00
$17.44
Analyst Decision
Hold
Analyst Count
0
14
Target Price
N/A
$17.31
AVG Volume (30 Days)
3.4M
348.3K
Earning Date
03-19-2026
02-18-2026
Dividend Yield
13.09%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$7,960,960,695.00
$4,976,000,000.00
Revenue This Year
N/A
$8.06
Revenue Next Year
N/A
$5.79
P/E Ratio
$8.36
N/A
Revenue Growth
9.92
6.23
52 Week Low
$1.59
$10.45
52 Week High
$2.30
$18.14

Technical Indicators

Market Signals
Indicator
CIG
BLCO
Relative Strength Index (RSI) 46.73 60.09
Support Level $1.95 $17.02
Resistance Level $2.04 $17.86
Average True Range (ATR) 0.04 0.41
MACD -0.00 -0.01
Stochastic Oscillator 32.14 74.39

Price Performance

Historical Comparison
CIG
BLCO

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: